Literature DB >> 8373267

Creation of a neo-aortoiliac system from lower extremity deep and superficial veins.

G P Clagett1, B L Bowers, M A Lopez-Viego, M B Rossi, R J Valentine, S I Myers, A Chervu.   

Abstract

OBJECTIVE: This study evaluated the morbidity, mortality, and intermediate term follow-up of patients undergoing replacement of their aortoiliac-femoral systems with lower extremity deep and superficial veins. SUMMARY BACKGROUND DATA: The most commonly used treatment for aortic prosthetic infection is ectopic bypass and removal of the prosthesis. The overall mortality rate with this approach is approximately 20%, with an amputation rate of 10% to 14%. Other limitations include thrombosis of the ectopic bypass leading to limb loss, reinfection of the ectopic bypass, and aortic stump blowout. Dissatisfaction with this approach has led the authors to develop the following.
METHODS: A neo-aortoiliac system (NAIS) was fashioned from lower extremity deep veins (DV), greater saphenous veins (GSV), or both in patients with infected aortobifemoral prosthesis (n = 17) and other complex aortic problems (n = 3). Removal of infected prosthetic material, harvest of vein, and creation of NAIS was performed as a single-staged procedure.
RESULTS: The in-hospital mortality and amputation rates were 10% each. The mean (+/- standard deviation [SD]) operative time was 6.5 +/- 1.8 hours and the blood transfusion requirement was 4 +/- 3 units. Four patients experienced postoperative gastrointestinal complications with peritonitis and sepsis; NAIS vein graft resisted infection and remained intact. The mean follow-up time was 22.5 +/- 16 months. NAISs constructed from GSVs were prone to the development of focal stenoses requiring intervention or diffuse neointimal hyperplasia leading to occlusion. In contrast, all NAISs from larger caliber DVs have remained widely patent. The failure rate of GSV NAISs was 64%, compared to 0% for DV NAISs (p = 0.006). Despite the high failure rate in patients with GSV NAISs, none has required amputation. In patients who had DVs harvested for NAIS reconstruction, limb edema and other signs of venous hypertension have been minimal.
CONCLUSION: NAIS reconstruction from lower extremity veins is a successful option in patients with extensive aortic prosthetic infection and other complex aortic problems.

Entities:  

Mesh:

Year:  1993        PMID: 8373267      PMCID: PMC1242955          DOI: 10.1097/00000658-199309000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  Aortobifemoral bypass with autogenous saphenous vein in treatment of paninfected aortic bifurcation graft.

Authors:  J E Lorentzen; O M Nielsen
Journal:  J Vasc Surg       Date:  1986-04       Impact factor: 4.268

2.  Infected aortobifemoral prosthesis--a dreaded complication.

Authors:  J Schellack; M T Stewart; R B Smith; G D Perdue; A Salam
Journal:  Am Surg       Date:  1988-03       Impact factor: 0.688

3.  Synthetic vascular graft infections. II. Graft-enteric erosions and graft-enteric fistulas.

Authors:  T J Bunt
Journal:  Surgery       Date:  1983-07       Impact factor: 3.982

4.  Aortic and peripheral prosthetic graft infection: differential management and causes of mortality.

Authors:  R A Yeager; D B McConnell; T M Sasaki; R M Vetto
Journal:  Am J Surg       Date:  1985-07       Impact factor: 2.565

5.  Superficial femoral-popliteal veins and reversed saphenous veins as primary femoropopliteal bypass grafts: a randomized comparative study.

Authors:  M L Schulman; M R Badhey; R Yatco
Journal:  J Vasc Surg       Date:  1987-07       Impact factor: 4.268

6.  The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft.

Authors:  W E Walker; D A Cooley; J M Duncan; G L Hallman; D A Ott; G J Reul
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

Review 7.  Freshly harvested cadaveric venous homografts as arterial conduits in infected fields.

Authors:  S O Snyder; J R Wheeler; R T Gregory; R G Gayle; P K Zirkle
Journal:  Surgery       Date:  1987-03       Impact factor: 3.982

8.  Improved management of aortic graft infection: the influence of operation sequence and staging.

Authors:  L M Reilly; R J Stoney; J Goldstone; W K Ehrenfeld
Journal:  J Vasc Surg       Date:  1987-03       Impact factor: 4.268

9.  Surgical management of infected abdominal aortic grafts: review of a 25-year experience.

Authors:  P J O'Hara; N R Hertzer; E G Beven; L P Krajewski
Journal:  J Vasc Surg       Date:  1986-05       Impact factor: 4.268

10.  Arterial graft infections. Delayed v immediate vascular reconstruction.

Authors:  W D Turnipseed; H A Berkoff; D E Detmer; C W Acher; F O Belzer
Journal:  Arch Surg       Date:  1983-04
View more
  20 in total

Review 1.  Late Stent Graft Infection after the Emergency Endovascular Repair of a Secondary Iliac Artery-Enteric Fistula Treated with Graft Removal and In Situ Aortic Reconstruction Using Femoral Veins.

Authors:  Yohei Yamamoto; Kimihiro Igari; Takahiro Toyofuku; Toshifumi Kudo; Yoshinori Inoue
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-07-08       Impact factor: 1.520

2.  Salmonella-related mycotic pseudoaneurysm of the superficial femoral artery.

Authors:  Marcus Vinícius Martins Cury; Maysa Heineck de Campos; Diogo Pires Dos Santos
Journal:  Int J Surg Case Rep       Date:  2011-10-25

3.  Experimental evaluation of four biologic prostheses for ventral hernia repair.

Authors:  Wolfgang B Gaertner; Margaret E Bonsack; John P Delaney
Journal:  J Gastrointest Surg       Date:  2007-08-03       Impact factor: 3.452

4.  Cyanoacrylate for wound closure in prosthetic vascular graft surgery to prevent infections through contamination.

Authors:  Murat Aksoy; Erhan Turnadere; Kemal Ayalp; Murat Kayabali; Bulent Ertugrul; Levent Bilgic
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  Quality of life and the venous function of the lower limb after harvest of autologous external iliac vein grafts: a clinical follow-up study.

Authors:  Yuji Kaneoka; Atsuyuki Maeda; Masayuki Sugimoto; Masatoshi Isogai; Hiroyuki Ishibashi
Journal:  Surg Today       Date:  2012-11-10       Impact factor: 2.549

Review 6.  Treatment of Aortic Graft Infection in the Endovascular Era.

Authors:  Rebecca Sorber; Michael J Osgood; Christopher J Abularrage; James H Black; Ying Wei Lum
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

7.  Surgical outcome of autologous external iliac vein grafting in cases of hepato-pancreato-biliary malignancy: how I do it.

Authors:  Yuji Kaneoka; Atsuyuki Maeda; Masatoshi Isogai
Journal:  J Gastrointest Surg       Date:  2012-06-15       Impact factor: 3.452

8.  Management of vascular infection in the groin.

Authors:  Cagatay Engin; Hakan Posacioglu; Fatih Ayik; Anil Ziya Apaydin
Journal:  Tex Heart Inst J       Date:  2005

9.  Selective preservation of infected prosthetic arterial grafts. Analysis of a 20-year experience with 120 extracavitary-infected grafts.

Authors:  K D Calligaro; F J Veith; M L Schwartz; J Goldsmith; R P Savarese; M J Dougherty; D A DeLaurentis
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

10.  Hybrid in situ replacement for Samson group V Staphylococcus aureus aortic graft infection.

Authors:  A A Karpenko; P V Ignatenko; A M Beliaev
Journal:  BMJ Case Rep       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.